Published Date: Feb-19
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report North America Cardiac Pacemaker Market, published by KBV research, the North America Cardiac Pacemaker Market would witness market growth of 6.1% CAGR during the forecast period (2018 – 2024).
The US market would dominate the North America Single-Chamber Cardiac Pacemakers Market by Country 2024, growing at a CAGR of 5.1 % during the forecast period. The Canada market is expected to witness a CAGR of 5.8% during (2018 - 2024). Additionally, The Mexico market is expected to witness a CAGR of 7.9% during (2018 - 2024).
The Single-Chamber Cardiac Pacemakers market dominated the North America Cardiac Pacemaker Market by Technology 2017, thereby, achieving a market value of $1,612.7 million by 2024. The Dual-Chamber Cardiac Pacemakers market is expected to witness a CAGR of 6.5% during (2018 - 2024).
The Hospitals market dominated the Mexico Cardiac Pacemaker Market by End User 2017, growing at a CAGR of 8.5 % during the forecast period. The Ambulatory Surgery Centers (ASCs) market is expected to witness a CAGR of 8% during (2018 - 2024).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories (U.S.), Boston Scientific Corporation, Biotronik SE & Co. KG, Lepu Medical Technology Co ltd, Cook Medical Group, Medico S.p.A, LivaNova PL, Osypka Medical GmbH, Shree Pacetronix Ltd. and Medline Industries, Inc.
North America Cardiac Pacemaker Market Segmentation
By End User
Unique Offerings from KBV Research